Article ID Journal Published Year Pages File Type
3331770 Hematology/Oncology Clinics of North America 2009 19 Pages PDF
Abstract

Plasma cell myeloma is a heterogenous disease with variable clinical presentation and outcome. The prognosis is largely determined by tumor biology. Newer therapeutic agents are rapidly changing the survival outlook of myeloma patients.

Related Topics
Health Sciences Medicine and Dentistry Hematology
Authors
,